Aprea Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Aprea Therapeutics

10/11/2022 01:12

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of 12 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aprea Therapeutics Inc shares had fallen by 6.2% this
quarter and lost 78.7% so far this year.
    * The company reported a quarterly loss of $4.02 million.
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $3.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 01:12 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.27          -0.12          Beat
 Jun. 30 2022      -0.37          -0.98          Missed
 Mar. 31 2022      -0.38          -0.36          Beat
 Dec. 31 2021      -0.44          -0.36          Beat